The Food and Drug Administration (FDA) has approved Boston Scientific's stroke prevention device as an alternative to blood thinners like warfarin to help reduce the risk of stroke in patients with non-valvular atrial fibrillation.
The device works as a filter that prevents blood clots from traveling to the brain, thereby causing a stroke; the device is positioned within the left atrial appendage. By installing this device, patients would not be required to be on blood thinners that have side effects like high risk of bleeding.
Heat Stroke
Heat stroke is caused when body temperature or hyperthermia exceeds 40.6°C or 105.1°F. Heat stroke can be triggered due to overwork during summer months and lack of perspiration.
Advertisement
The device is available in five different sizes to match each patient's own anatomy; the frame is made of Nitinol. It has ten anchors that help the device to stay aligned and in place, while the PET mesh promotes the growth of endothelial cells.
Boston Scientific received approval from the FDA after two failed attempts; the product at the time showed complications arising from efficacy and complexity during implantation. Approval was given based on the robust WATCHMAN clinical program with numerous studies. The clinical program results showed that the device can be implanted safely and reduces the risk of stroke in patients with non-valvular atrial fibrillation, enabling them to discontinue warfarin.
The device provides patients with a comparable protection against stroke, reduction in hemorrhagic stroke, disabling stroke and cardiovascular death compared to warfarin over long term follow-up.
Source: Medindia
The device provides patients with a comparable protection against stroke, reduction in hemorrhagic stroke, disabling stroke and cardiovascular death compared to warfarin over long term follow-up.
Source: Medindia
How to Deal with a Stroke
Stroke is a brain attack, which occurs when the blood supply to the brain is interrupted. It affects all age groups; according to the WHO, 15 million people are affected by stroke annually.
Advertisement
 Apixaban : New Stroke Drug Available on NHSA new drug apixaben is now available that can treat stroke resulting from atrial fibrillation more effectively. | Advertisement
|
Younger People, Too, at the Risk of Stroke
Younger people, too, are at the risk of suffering from stokes, a new study explained and warned about the rise of stroke by the year 2030
Advertisement
Recommended Reading
Latest Medical Gadgets
A novel type of neural implant was found to restore limb function to amputees. The implant sheds insights into brain-machine interfaces.
The wearable sensor for muscle atrophy, the muscle condition can be used by an astronaut on a long mission to keep track of his health.
Newly developed custom 3D-printed heart replicas look and pump just like real human heart.
What is the market size for surgical robotics? The market size is expected to expand at a compound annual growth rate (CAGR) of 18.0% from 2023 to 2030.
Is the Apple Watch a life-saver? Yes, the Apple Watch 7 saves the wearer's life by alerting about fatal internal bleeding following a nap.